Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125043692 | 12504369 | 2 | F | 20140414 | 20160805 | 20160628 | 20160812 | EXP | JP-JNJFOC-20140609586 | JANSSEN | 44.55 | YR | A | M | Y | 0.00000 | 20160812 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125043692 | 12504369 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | Y | N | 21976 | 400 | MG | TABLETS | BID | |||||
| 125043692 | 12504369 | 2 | SS | EDURANT | RILPIVIRINE HYDROCHLORIDE | 1 | Oral | Y | N | 202022 | 25 | MG | TABLETS | QD | |||||
| 125043692 | 12504369 | 3 | SS | NORVIR | RITONAVIR | 1 | Oral | Y | 0 | 100 | MG | UNSPECIFIED | QD | ||||||
| 125043692 | 12504369 | 4 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 125043692 | 12504369 | 5 | C | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 0 | 2 | DF | TABLET | BID | |||||||
| 125043692 | 12504369 | 6 | C | BIO-THREE | HERBALS | 1 | Oral | 0 | 2 | DF | TABLET | TID | |||||||
| 125043692 | 12504369 | 7 | C | BIO-THREE | HERBALS | 1 | Oral | 0 | 2 | DF | TABLET | TID | |||||||
| 125043692 | 12504369 | 8 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | Oral | 0 | 2 | DF | TABLET | BID | |||||||
| 125043692 | 12504369 | 9 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | Oral | 0 | 2 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125043692 | 12504369 | 1 | HIV infection |
| 125043692 | 12504369 | 2 | HIV infection |
| 125043692 | 12504369 | 3 | HIV infection |
| 125043692 | 12504369 | 4 | HIV infection |
| 125043692 | 12504369 | 5 | HIV infection |
| 125043692 | 12504369 | 6 | Diarrhoea |
| 125043692 | 12504369 | 7 | Diarrhoea |
| 125043692 | 12504369 | 8 | Diarrhoea |
| 125043692 | 12504369 | 9 | Diarrhoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125043692 | 12504369 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125043692 | 12504369 | Diabetic nephropathy | |
| 125043692 | 12504369 | Glucose tolerance impaired | |
| 125043692 | 12504369 | Liver disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125043692 | 12504369 | 1 | 20100301 | 20130707 | 0 | |
| 125043692 | 12504369 | 2 | 20130708 | 20150906 | 0 | |
| 125043692 | 12504369 | 3 | 20100301 | 20130707 | 0 | |
| 125043692 | 12504369 | 4 | 20081029 | 20150906 | 0 | |
| 125043692 | 12504369 | 5 | 20081029 | 20100301 | 0 | |
| 125043692 | 12504369 | 6 | 20081117 | 20081205 | 0 | |
| 125043692 | 12504369 | 7 | 20090302 | 20090608 | 0 | |
| 125043692 | 12504369 | 8 | 20090803 | 20091005 | 0 | |
| 125043692 | 12504369 | 9 | 20100401 | 20110418 | 0 |